{"metadata": {"source": "psychonaut", "title": "LSD - PsychonautWiki", "description": "Lysergic acid diethylamide (also known as Lysergide, LSD-25, LSD, L, Lucy, and Acid) is a classical psychedelic substance of the lysergamide class.[2] It is perhaps the most researched and culturally influential psychedelic substance, as well as the prototypal lysergamide. The mechanism of action is not fully known, although serotonin binding activity is thought to be involved.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/LSD", "drug": "LSD", "cid": 5761, "char_count": 85077, "word_count": 12291, "doc_id": "doc_85", "num_chunks": 107, "chunk_id": "85::chunk_74", "document_index": 85, "latency_s": 0.9091071000002557, "prompt_toks": 22519, "completion_toks": 58, "relevance_score": 5.214498e-06}, "content": "Drug: LSD | cid: 5761\nSource: psychonaut | Source description: Lysergic acid diethylamide (also known as Lysergide, LSD-25, LSD, L, Lucy, and Acid) is a classical psychedelic substance of the lysergamide class.[2] It is perhaps the most researched and culturally influential psychedelic substance, as well as the prototypal lysergamide. The mechanism of action is not fully known, although serotonin binding activity is thought to be involved.\n\n                    Text: \n                    ↑ Users are advised to monitor their core temperature and be cautious if taking LSD in hot or overcrowded outdoor environments.\n\n↑ It is advised to eat a medium sized meal two to three hours before a trip to ensure one has enough energy to last through the whole trip. During the trip, the user may want to eat snacks like fruits or nuts or smoothies instead of full meals to avoid nausea and gastric discomfort.\n\nReferences\n\n↑ Dolder, P. C., Schmid, Y., Haschke, M., Rentsch, K. M., Liechti, M. E. (January 2016). \"Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans\". International Journal of Neuropsychopharmacology. 19 (1): 1–7. doi:10.1093/ijnp/pyv072. ISSN 1461-1457.\n\n↑ 2.0 2.1 2.2 Nichols, David E. (2016). Barker, Eric L., ed. \"Psychedelics\". Pharmacological Reviews. 68 (2): 264–355. doi:10.1124/pr.115.011478. eISSN 1521-0081. ISSN 0031-6997.\n\n\n                    Context: \n                    This section provides essential safety guidelines for LSD use, advising users to monitor core temperature in hot environments and to eat a medium meal before a trip to maintain energy and reduce nausea. It highlights harm reduction practices relevant to user safety and is supported by scientific references on LSD pharmacokinetics and effects.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid MDMA Vault: Basics", "description": "A summary of basic information about MDMA and its use.", "language": "No language found.", "url": "https://www.erowid.org/chemicals/mdma/mdma_basics.shtml", "drug": "MDMA", "cid": 1615, "substance": "mdma", "category": "CHEMICALS", "erowid_column": "Basics", "char_count": 15177, "word_count": 2352, "doc_id": "doc_163", "num_chunks": 21, "chunk_id": "163::chunk_9", "document_index": 163, "latency_s": 2.5673700999905122, "prompt_toks": 3750, "completion_toks": 49, "relevance_score": 4.0294567e-06}, "content": "Drug: MDMA | cid: 1615\nSource: erowid | Source description: A summary of basic information about MDMA and its use.\nErowid name: mdma\nCategory: CHEMICALS\nField: Basics\n\n                    Text: \n                    Terminology / Slang #\n\nThe Substance:\n\nMDMA; Ecstasy; X; XTC; E; M; Adam; Molly, Thizz, Beans (Tablets); Rolls.\n\nThe Experience:\n\nRolling; X-ing; Thizzing; Wigging; Tripping.\n\nEFFECTS #\n\nWhen the full effects of MDMA manifest, barring an uncommon negative reaction, users are likely to find that suddenly everything is right with the world. The primary effects sought by those using MDMA recreationally are the emotional openness, euphoria, stimulation, reduction of critical and cynical thoughts, and decrease of inhibitions that can accompany its use. MDMA is used by some individuals in a therapeutic setting to attempt to work through difficult interpersonal issues. Although MDMA can cause nystagmus (eye wiggles), most individuals experience few prominent open or closed eye visuals. A small percentage of users report significant visual distortions.\n\nOnset #\n\n\n                    Context: \n                    This section provides key terminology, slang, and effects descriptions related to MDMA, including common street names, user experience terms, and primary effects such as emotional openness and euphoria, situating it within the broader informational overview of MDMA on the webpage.\n                "}
{"metadata": {"source": "psychonaut", "title": "MDMA - PsychonautWiki", "description": "3,4-Methylenedioxymethamphetamine (also known as ecstasy, E, XTC, emma, molly, mandy, pingers, and MDMA) is a classical entactogen substance of the amphetamine class. \nIt is the most well-known and widely-used member of the entactogens, a diverse group that includes MDA, methylone, 4-MMC, and 6-APB. It produces its effects by promoting the release of serotonin, dopamine, and norepinephrine in the brain, particularly serotonin.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/MDMA", "drug": "MDMA", "cid": 1615, "char_count": 74065, "word_count": 10533, "doc_id": "doc_82", "num_chunks": 98, "chunk_id": "82::chunk_45", "document_index": 82, "latency_s": 1.0731854000041494, "prompt_toks": 18884, "completion_toks": 68, "relevance_score": 2.6016164e-06}, "content": "Drug: MDMA | cid: 1615\nSource: psychonaut | Source description: 3,4-Methylenedioxymethamphetamine (also known as ecstasy, E, XTC, emma, molly, mandy, pingers, and MDMA) is a classical entactogen substance of the amphetamine class. \nIt is the most well-known and widely-used member of the entactogens, a diverse group that includes MDA, methylone, 4-MMC, and 6-APB. It produces its effects by promoting the release of serotonin, dopamine, and norepinephrine in the brain, particularly serotonin.\n\n                    Text: \n                    Experience:0.75g MDMA - Possibly some MDA through metabolisation?\n\nExperience:150mg MDMA + 20mg 2C-B - I designed it this way myself\n\nExperience:250mg MDA / 250mg MDMA - unnecessarily large dosage\n\nExperience:250mg MDMA (oral) - Pareidolia & paranoia\n\nExperience:450mg MDMA - Quarter consumption through whole night\n\nExperience:Cannabis, Ecstasy (3 brownies, 1 pill, Oral) My happy friends Shadow People\n\nExperience:MDMA (1/2 tab, oral) - My first time ever being high\n\nExperience:MDMA (100 mg) + Cannabis - Trip Report\n\nExperience:MDMA (750mg, Oral) - Finally Free\n\nExperience:MDMA (80mg, rectal) - Comments on rectal bioavailability\n\nExperience:MDMA or MDA, 580mg, Oral\n\nExperience:Nightmare flipping\n\nAdditional experience reports can be found here:\n\nErowid Experience Vaults: MDMA\n\nNames and forms\n\nNames\n\nMDMA pills, commonly called Ecstasy\n\nOff-white MDMA crystals, commonly called Molly\n\n\n                    Context: \n                    This section presents user experience reports detailing various doses, combinations, and effects of MDMA, highlighting real-world perspectives within the broader discussion of MDMA effects, usage, and harm reduction. It also covers common street names and physical forms like pills (\"Ecstasy\") and crystals (\"Molly\"), providing practical context for identifying and understanding MDMA in recreational settings.\n                "}
